Zeiss and Ilmenau University open new research lab

Article

Carl Zeiss Meditec AG and the Ilmenau University, Germany, have formed a partnership to open a new ophthalmic laboratory at the Institut für Biomedizinische Technik und Informatik in Germany.

Carl Zeiss Meditec AG and the Ilmenau University, Germany, have formed a partnership to open a new ophthalmic laboratory at the Institut für Biomedizinische Technik und Informatik in Germany.

The laboratory is distinguished by housing the latest in diagnostic systems, particularly those used for the examination of the posterior segment. There are to be three main areas of research: to combine previously independent examination methods, to develop more powerful systems with easily interpretable diagnostic data for the early detection of eye disorders and to integrate diagnosis with therapy in a comprehensive patient-orientated treatment approach.

The main aim of these projects is to develop early diagnosis and improved monitoring of eye disorders such as glaucoma, diabetic retinopathy, age-related macular degeneration and arterial/venous occlusion.

The laboratory was made possible by "research and development infrastructure" support from the Thuringian Ministry of Education and Arts.

Elsewhere, Dr Michael Kaschke, Director of Carl Zeiss AG and Chairman of the Supervisory Board of Carl Zeiss Meditec AG, has also announced the opening of the first training centre for ophthalmology at the Cicendo Hospital in Bandung, Indonesia, together with Dr Gullapalli N. Rao, President of IAPB (International Agency for the Prevention of Blindness) and representatives of the Indonesian government.

Carl Zeiss is supporting the foundation of the training centre with a donation of $200,000, which will be used for training staff and equipping the centre. The company also donated several systems for diagnosis, treatment and aftercare, including slit lamps, treatment lasers and a surgical microscope.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.